{"id":"https://openalex.org/W2031908394","doi":"https://doi.org/10.1097/00004714-198808000-00008","title":"Tranylcypromine in Social Phobia","display_name":"Tranylcypromine in Social Phobia","publication_year":1988,"publication_date":"1988-08-01","ids":{"openalex":"https://openalex.org/W2031908394","doi":"https://doi.org/10.1097/00004714-198808000-00008","mag":"2031908394","pmid":"https://pubmed.ncbi.nlm.nih.gov/3209719"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-198808000-00008","doi":"https://doi.org/10.1097/00004714-198808000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-198808000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109113043","display_name":"M\u00e1rcio Versiani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"MARCIO VERSIANI","raw_affiliation_strings":["Department of Psychiatry, Federal University of Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Federal University of Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038863577","display_name":"F D Mundim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. DINIZ MUNDIM","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112340805","display_name":"Antonio E. Nardi","orcid":"https://orcid.org/0000-0002-2152-4669","observed_orcids":["https://orcid.org/0000-0002-2152-4669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. EGIDIO NARDI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032136657","display_name":"Michael R. Liebowitz","orcid":"https://orcid.org/0000-0002-8990-8845","observed_orcids":["https://orcid.org/0000-0002-8990-8845"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MICHAEL R. LIEBOWITZ","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7865,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.96100882,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"8","issue":"4","first_page":"279???282","last_page":"279???282"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tranylcypromine","display_name":"tranylcypromine","score":1.0},{"id":"https://openalex.org/keywords/social-anxiety-disorder","display_name":"social anxiety disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antidepressant-treatment","display_name":"antidepressant treatment","score":0.4869999885559082},{"id":"https://openalex.org/keywords/long-term-drug-therapy","display_name":"long-term drug therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/alcohol-abuse","display_name":"alcohol abuse","score":0.8370000123977661},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.9010000228881836},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7519999742507935},{"id":"https://openalex.org/keywords/phenelzine","display_name":"phenelzine","score":0.6790000200271606},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C2777118369","wikidata":"https://www.wikidata.org/wiki/Q420885","display_name":"Tranylcypromine","level":4,"score":0.893755316734314},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.844185471534729},{"id":"https://openalex.org/C2781073023","wikidata":"https://www.wikidata.org/wiki/Q1747559","display_name":"Phenelzine","level":4,"score":0.6952335834503174},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5058491230010986},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47508350014686584},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46573084592819214},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.43773266673088074},{"id":"https://openalex.org/C2780931562","wikidata":"https://www.wikidata.org/wiki/Q7331102","display_name":"Alcohol abuse","level":2,"score":0.42278924584388733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3695017099380493},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001960","descriptor_name":"Bromazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D014191","descriptor_name":"Tranylcypromine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014191","descriptor_name":"Tranylcypromine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-198808000-00008","doi":"https://doi.org/10.1097/00004714-198808000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-198808000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:3209719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3209719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.44999998807907104,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W54560054","https://openalex.org/W2437663356","https://openalex.org/W2049702187","https://openalex.org/W2001168479","https://openalex.org/W1968872519","https://openalex.org/W2049821022","https://openalex.org/W2369704381","https://openalex.org/W2010198608","https://openalex.org/W2021886489","https://openalex.org/W2010983145"],"abstract_inverted_index":{"Thirty-two":[0],"patients":[1],"meeting":[2],"DSM-III":[3],"criteria":[4],"for":[5],"social":[6],"phobia":[7],"entered":[8],"a":[9,51,88],"1-year":[10],"drug":[11],"treatment":[12],"with":[13,50,87,91],"tranylcypromine":[14],"in":[15,35,59,85,96],"dosages":[16,67],"between":[17],"40":[18],"and":[19,33,37,58],"60":[20],"mg/day.":[21],"After":[22],"exclusion":[23],"of":[24,39,65,72],"the":[25,40,63,69],"early":[26],"dropouts,":[27],"improvement":[28],"was":[29,48],"rated":[30],"as":[31],"marked":[32],"moderate":[34],"62%":[36],"17%":[38],"sample":[41],"(N":[42],"=":[43],"29),":[44],"respectively.":[45],"Alcohol":[46],"abuse":[47],"associated":[49],"poor":[52],"outcome.":[53],"Side":[54],"effects":[55],"were":[56],"frequent":[57],"some":[60],"cases":[61],"delayed":[62],"attainment":[64],"efficacious":[66],"until":[68],"third":[70],"month":[71],"treatment.":[73],"No":[74],"serious":[75],"adverse":[76],"reactions":[77],"occurred.":[78],"The":[79],"findings,":[80],"relative":[81],"to":[82],"efficacy,":[83],"are":[84],"accordance":[86],"previous":[89],"trial":[90],"phenelzine":[92],"but":[93],"need":[94],"confirmation":[95],"double":[97],"blind":[98],"controlled":[99],"studies.":[100]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}